Al-Tawfiq, Jaffar A., Memish, Ziad A., 2014. What are our pharmatherapeutic
options for MERS-CoV?. Expert Rev. Clin. Pharmacol, 7(3): 235-238.
Assiri abdullah M Det al., 2013. Hospital Outbreak of Middle East Respiratory
Syndrome Coronavirus, vol 369 , no:5
Basem et al., 2016. Risk Factors For Primary Middle East Respiratory Syndrome
Coronavirus Illness In Humans, Saudi Arabia, 2014, Vol 22, no 1
Cunha, Ceston B., Opal, Steven M., 2014. Middle East Respiratory Syndrome
(MERS) A new zoonotic viral pneumonia. Virulence, 5(6):650-654.
Durai, P., Batool, M., Shah, M., Choi, S., 2015. Middle East Respiratory Syndrome
Coronavirus: Transmission, Virology And Therapeutic Targeting To Aid
Inoutbreak Control. Experimental & Moleculer Med, 47: 1-9.
Dyall. J., Coleman, CM., Hart, Brit J., Venkataraman, T., 2014. Repurposing Of
Clinically Developed for Treatment of Middle East Respiratory Syndrome
Coronavirus Infection. Antimicrobial Agents and Chemotherapy, 58(8): 4885-
4893.
Momattin, H., Mohammed, Khurram., Zumla, A., Memish, ZA., Al-Tawfiq, JA.,
2013., Therapeutic Options For Middle East Respiratory Syndrome Coronavirus
(MERS-Cov)-Possible Lessons From A Systematic Review of SARS-CoV
Therapy. Int J Infect Diseas, 17:729-798.
Van den Brand, JMA., Smits, Saskia L., Haagmans, Bart L., 2015. Pathogenesis of
Middle Respiratory Syndrome Coronavirus. J Pathol, 235:175-184.